Long-term efficacy and genomic characteristics of patients with TRK fusion lung cancer treated with larotrectinib Meeting Abstract


Authors: Moreno Garcia, V.; Lin, J.; Patel, J.; Lassen, U.; Solomon, B.; Rosen, L.; Leyvraz, S.; Tan, D. S. W.; Reeves, J. A.; Beckmann, G.; Rudolph, M.; Wierzbinska, J.; Dima, L.; Brega, N.; Kummar, S.; Drilon, A.
Abstract Title: Long-term efficacy and genomic characteristics of patients with TRK fusion lung cancer treated with larotrectinib
Meeting Title: European Lung Cancer Virtual Congress (ELCC 2021 Virtual)
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 4 Suppl.
Meeting Dates: 2021 Mar 25-27
Meeting Location: Virtual Conference
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-04-01
Start Page: S786
End Page: S787
Language: English
ACCESSION: WOS:000634855900160
PROVIDER: wos
DOI: 10.1016/S1556-0864(21)02004-9
Notes: Meeting Abstract: 162P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    637 Drilon